-
12
-
-
0029145533
-
-
S. Top H. El Hafa A. Vessières J. Quivy J. Vaissermann D. W. Hughes M. J. McGlinchey J. P. Moron E. Thoreau G. Jaouen J. Am. Chem. Soc. 1995 117 8372
-
(1995)
J. Am. Chem. Soc.
, vol.117
, pp. 8372
-
-
Top, S.1
El Hafa, H.2
Vessières, A.3
Quivy, J.4
Vaissermann, J.5
Hughes, D.W.6
McGlinchey, M.J.7
Moron, J.P.8
Thoreau, E.9
Jaouen, G.10
-
13
-
-
33748242024
-
-
A. Vessieres S. Top C. Vaillant D. Osella J.-P. Mornon G. Jaouen Angew. Chem., Int. Ed. Engl. 1992 31 753
-
(1992)
Angew. Chem., Int. Ed. Engl.
, vol.31
, pp. 753
-
-
Vessieres, A.1
Top, S.2
Vaillant, C.3
Osella, D.4
Mornon, J.-P.5
Jaouen, G.6
-
19
-
-
0041977178
-
-
S. Top E. B. Kaloun A. Vessieres G. Leclercq I. Laios M. Ourevitch C. Deuschel M. J. McGlinchey G. Jaouen ChemBioChem 2003 4 754
-
(2003)
ChemBioChem
, vol.4
, pp. 754
-
-
Top, S.1
Kaloun, E.B.2
Vessieres, A.3
Leclercq, G.4
Laios, I.5
Ourevitch, M.6
Deuschel, C.7
McGlinchey, M.J.8
Jaouen, G.9
-
22
-
-
11144356615
-
-
C. Cassino E. Gabano M. Ravera G. Cravotto G. Palmisano A. Vessières G. Jaouen S. Mundwiler R. Alberto D. Osella Inorg. Chim. Acta 2004 357 2157
-
(2004)
Inorg. Chim. Acta
, vol.357
, pp. 2157
-
-
Cassino, C.1
Gabano, E.2
Ravera, M.3
Cravotto, G.4
Palmisano, G.5
Vessières, A.6
Jaouen, G.7
Mundwiler, S.8
Alberto, R.9
Osella, D.10
-
24
-
-
7044226176
-
-
V. Gagnon M. E. St-Germain C. Descôteaux J. Provencher-Mandeville S. Parent S. K. Mandal E. Asselin G. Bérubé Bioorg. Med. Chem. Lett. 2004 14 5919
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 5919
-
-
Gagnon, V.1
St-Germain, M.E.2
Descôteaux, C.3
Provencher-Mandeville, J.4
Parent, S.5
Mandal, S.K.6
Asselin, E.7
Bérubé, G.8
-
26
-
-
33750576888
-
-
M. J. Hannon P. S. Green D. M. Fisher P. J. Derrick J. L. Beck S. J. Watt M. M. Sheil P. R. Barker N. W. Alcock R. J. Price K. J. Sanders R. Pither J. Davis A. Rodger Chem.-Eur. J. 2006 12 8000
-
(2006)
Chem.-Eur. J.
, vol.12
, pp. 8000
-
-
Hannon, M.J.1
Green, P.S.2
Fisher, D.M.3
Derrick, P.J.4
Beck, J.L.5
Watt, S.J.6
Sheil, M.M.7
Barker, P.R.8
Alcock, N.W.9
Price, R.J.10
Sanders, K.J.11
Pither, R.12
Davis, J.13
Rodger, A.14
-
33
-
-
0031839905
-
-
M. R. Cardillo E. Petrangeli N. Aliotta L. Salvatori L. Ravenna C. Chang G. Castagna J. Exp,. Clin. Cancer Res. 1998 17 231
-
(1998)
J. Exp,. Clin. Cancer Res.
, vol.17
, pp. 231
-
-
Cardillo, M.R.1
Petrangeli, E.2
Aliotta, N.3
Salvatori, L.4
Ravenna, L.5
Chang, C.6
Castagna, G.7
-
36
-
-
0035408472
-
-
I. Leav K. M. Lau J. Y. Adams J. E. McNeal M. E. Taplin J. F. Wang H. Singh S. M. Ho Am. J. Pathol 2001 159 79
-
(2001)
Am. J. Pathol
, vol.159
, pp. 79
-
-
Leav, I.1
Lau, K.M.2
Adams, J.Y.3
McNeal, J.E.4
Taplin, M.E.5
Wang, J.F.6
Singh, H.7
Ho, S.M.8
-
38
-
-
0343698426
-
-
J. A. R. Dewinter P. J. A. Janssen M. C. T. Verleunmooijman J. Trapman A. O. Brinkmann A. B. Santerse F. H. Schroder T. H. Vanderkwast Am. J. Pathol 1994 144 735
-
(1994)
Am. J. Pathol
, vol.144
, pp. 735
-
-
Dewinter, J.A.R.1
Janssen, P.J.A.2
Verleunmooijman, M.C.T.3
Trapman, J.4
Brinkmann, A.O.5
Santerse, A.B.6
Schroder, F.H.7
Vanderkwast, T.H.8
-
39
-
-
47749127368
-
-
a platinum moiety was attached to a testosterone molecule. However, it was aimed towards ER and no cytotoxicity data was provided. For an example of an androgen targeting a radiopharmaceutical see
-
R. Schobert G. Bernhardt B. Biersack S. Bollwein M. Fallahi A. Grotemeier G. L. Hammond ChemMedChem 2007 2 333
-
(2007)
ChemMedChem
, vol.2
, pp. 333
-
-
Schobert, R.1
Bernhardt, G.2
Biersack, B.3
Bollwein, S.4
Fallahi, M.5
Grotemeier, A.6
Hammond, G.L.7
-
44
-
-
0034714276
-
-
P. M. Matias P. Donner R Coelho M. Thomaz C. Peixoto S. Macedo N. Otto S. Joschko P. Scholz A. Wegg S. Basler M. Schafer U. Egner M. A. Carrondo J. Biol. Chem. 2000 275 26164
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26164
-
-
Matias, P.M.1
Donner, P.2
Coelho, R.3
Thomaz, M.4
Peixoto, C.5
MacEdo, S.6
Otto, N.7
Joschko, S.8
Scholz, P.9
Wegg, A.10
Basler, S.11
Schafer, M.12
Egner, U.13
Carrondo, M.A.14
-
50
-
-
0024490797
-
-
50) As expected, the increase in activity observed by the testosterone-coupled 1.Pt-cis compared with its non-steroidal analogue (Py.Pt-cis) is twice in T47D (AR+) than in SKOV3 and MDA-MB-231 (AR-) cell lines
-
L. S. Hollis A. R. Amundsen E. W. Stern J. Med. Chem. 1989 32 128
-
(1989)
J. Med. Chem.
, vol.32
, pp. 128
-
-
Hollis, L.S.1
Amundsen, A.R.2
Stern, E.W.3
-
53
-
-
3843077805
-
-
D. I. Jodrell T. R. J. Evans W. Steward D. Cameron J. Prendiville C. Aschele C. Noberasco M. Lind J. Carmichael N. Dobbs G. Camboni B. Gatti F. De Braud Eur. J. Cancer 2004 40 1872
-
(2004)
Eur. J. Cancer
, vol.40
, pp. 1872
-
-
Jodrell, D.I.1
Evans, T.R.J.2
Steward, W.3
Cameron, D.4
Prendiville, J.5
Aschele, C.6
Noberasco, C.7
Lind, M.8
Carmichael, J.9
Dobbs, N.10
Camboni, G.11
Gatti, B.12
De Braud, F.13
-
55
-
-
0023111825
-
-
30μM was chosen as a good compromise of the activity of cisplatin and the steroidal-complexes through the chosen cell lines
-
B. C. Behrens T. C. Hamilton H. Masuda K. R. Grotzinger J. Whang-Peng K. G. Louie T. Knutsen W. M. McKoy R. C. Young R. F. Ozols Cancer Res. 1987 47 414
-
(1987)
Cancer Res.
, vol.47
, pp. 414
-
-
Behrens, B.C.1
Hamilton, T.C.2
Masuda, H.3
Grotzinger, K.R.4
Whang-Peng, J.5
Louie, K.G.6
Knutsen, T.7
McKoy, W.M.8
Young, R.C.9
Ozols, R.F.10
-
59
-
-
78649370819
-
-
10.1039/c0dt00839g
-
C. Sanchez-Cano M. Huxley C. Ducani A. E. Hamad M. J. Browning C. Navarro-Ranninger A. G. Quiroga A. Rodger M. J. Hannon Dalton Trans. 2010 39 10.1039/c0dt00839g
-
(2010)
Dalton Trans.
, vol.39
-
-
Sanchez-Cano, C.1
Huxley, M.2
Ducani, C.3
Hamad, A.E.4
Browning, M.J.5
Navarro-Ranninger, C.6
Quiroga, A.G.7
Rodger, A.8
Hannon, M.J.9
|